Provided by Tiger Trade Technology Pte. Ltd.

Novo-Nordisk A/S

45.84
-1.3500-2.86%
Volume:2.38M
Turnover:109.54M
Market Cap:202.75B
PE:11.45
High:46.12
Open:45.97
Low:45.72
Close:47.19
52wk High:64.16
52wk Low:35.12
Shares:4.42B
Float Shares:3.19B
Volume Ratio:3.40
T/O Rate:0.07%
Dividend:1.72
Dividend Rate:3.76%
EPS(TTM):4.00
EPS(LYR):3.62
ROE:59.82%
ROA:18.73%
PB:6.23
PE(LYR):12.66

Loading ...

European Equities Traded in the US as American Depositary Receipts Little Changed in Thursday Trading

MT Newswires Live
·
May 21

Mixed options sentiment in Novo Nordisk with shares down 2.12%

TIPRANKS
·
May 21

Live Longer and Better. Does Medicine's New Obsession Really Work? -- Barrons.com

Dow Jones
·
May 21

Singapore Court of Appeal Notes No Finding of Fraud Against KBP or Dr. Huang; Dispute with Novo Nordisk Undergoing Arbitration Proceedings

prnewswire
·
May 21

Novo Nordisk A/S Stock Rises Wednesday, Underperforms Market

Dow Jones
·
May 21

Deutsche Bank Remains a Hold on Novo Nordisk (0QIU)

TIPRANKS
·
May 20

Wegovy Liver Data Broadens Semaglutide Story For Novo Nordisk Investors

Simply Wall St.
·
May 20

Novo Nordisk Advances New Cagrilintide Study in the Race for Obesity Leadership

TIPRANKS
·
May 20

Novo Nordisk’s AMAZE 2 Trial: A New Weight-Loss Shot Targets Growth Beyond Semaglutide

TIPRANKS
·
May 20

Moderately bullish activity in Novo Nordisk with shares up 0.6%

TIPRANKS
·
May 19

Barclays Keeps Their Hold Rating on Novo Nordisk (0QIU)

TIPRANKS
·
May 19

Some people lose far more weight than others on GLP-1s like Wegovy. Here's why.

Dow Jones
·
May 19

PFE, NVO, LLY: Pharma Stocks Drop on News TrumpRx Set for ‘Dramatic Expansion’

TIPRANKS
·
May 19

Novo Nordisk A/S Stock Falls Monday, Underperforms Market

Dow Jones
·
May 19

Novo Nordisk Details Progress on DKK 15 Billion Share Buyback Programme

TIPRANKS
·
May 18

Big Pharma Firms Denied Certiorari by Supreme Court in Medicare Pricing Case

MT Newswires Live
·
May 18

Novo Nordisk Report Shows Bright Spots Amid Price Pressure -- Market Talk

Dow Jones
·
May 18

Novo Nordisk's Next Weight-Loss Battle: Winning Markets Beyond the U.S.

Deep News
·
May 18

Novo Nordisk Aims to Launch Oral Wegovy Weight-Loss Drug in Markets Beyond the U.S.

Deep News
·
May 18

Novo Nordisk’s Cagrilintide Trial Signals Next Wave in Obesity Treatment

TIPRANKS
·
May 16